Estrogens, esterified - Generic Drug Details

What are the generic sources for estrogens, esterified and what is the scope of patent protection?

Estrogens, esterified is the generic ingredient in six branded drugs marketed by Bristol Myers Squibb, Pvt Form, Sandoz, Solvay, Roche Palo, and Monarch Pharms, and is included in eighteen NDAs. Additional information is available in the individual branded drug profile pages.

Summary for estrogens, esterified

US Patents:	0
Tradenames:	6
Applicants:	6
NDAs:	18
Raw Ingredient (Bulk) Api Vendors:	109
Clinical Trials:	5
What excipients (inactive ingredients) are in estrogens, esterified?	estrogens, esterified excipients list
DailyMed Link:	estrogens, esterified at DailyMed

Recent Clinical Trials for estrogens, esterified

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
The Alfred	Phase 2
Stanley Medical Research Institute	Phase 2
Solvay Pharmaceuticals	Phase 2

See all estrogens, esterified clinical trials

US Patents and Regulatory Information for estrogens, esterified

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Solvay	ESTRATAB	estrogens, esterified	TABLET;ORAL	083209-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Sandoz	ESTERIFIED ESTROGENS	estrogens, esterified	TABLET;ORAL	085302-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Monarch Pharms	MENEST	estrogens, esterified	TABLET;ORAL	084951-001	Approved Prior to Jan 1, 1982		DISCN	No	No